Drug Profile
Research programme: antibody therapeutics - WuXi Biologics
Alternative Names: Neutralizing antibodies for 2019-nCoV - WuXi Biologics; Neutralizing antibodies for Coronavirus - WuXi BiologicsLatest Information Update: 28 Feb 2024
Price :
$50
*
At a glance
- Originator WuXi Biologics
- Class Antibodies; Antivirals
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported COVID 2019 infections